Drug
Acitretin
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Affect Lability | 198 | 90.4 | 94.2 | signal |
| 2 | Motor Dysfunction | 196 | 85.4 | 89.0 | signal |
| 3 | Skin Haemorrhage | 279 | 85.3 | 90.4 | signal |
| 4 | Sinus Congestion | 220 | 71.5 | 74.8 | signal |
| 5 | Muscle Spasticity | 198 | 70.2 | 73.1 | signal |
| 6 | Coordination Abnormal | 197 | 61.5 | 64.1 | signal |
| 7 | Respiratory Tract Congestion | 215 | 59.2 | 61.9 | signal |
| 8 | Hemiparesis | 196 | 50.3 | 52.4 | signal |
| 9 | Sinus Disorder | 218 | 48.1 | 50.3 | signal |
| 10 | Sneezing | 218 | 42.6 | 44.5 | signal |
| 11 | Eating Disorder | 195 | 39.8 | 41.4 | signal |
| 12 | Psoriasis | 1,184 | 39.5 | 52.0 | signal |
| 13 | Squamous Cell Carcinoma | 68 | 31.4 | 31.9 | signal |
| 14 | Psoriatic Arthropathy | 285 | 30.9 | 32.7 | signal |
| 15 | Angina Pectoris | 202 | 30.5 | 31.8 | signal |
| 16 | Aphasia | 205 | 29.5 | 30.7 | signal |
| 17 | Cystitis | 212 | 28.9 | 30.1 | signal |
| 18 | Dysarthria | 200 | 23.1 | 24.1 | signal |
| 19 | Skin Exfoliation | 372 | 19.4 | 21.0 | signal |
| 20 | Pain Of Skin | 109 | 17.5 | 17.9 | signal |
| 21 | Rhinorrhoea | 258 | 17.4 | 18.3 | signal |
| 22 | Candida Infection | 62 | 16.1 | 16.3 | signal |
| 23 | Oral Candidiasis | 46 | 15.3 | 15.5 | signal |
| 24 | Cataract | 201 | 14.7 | 15.3 | signal |
| 25 | Arthritis | 264 | 14.5 | 15.3 | signal |
| 26 | Hypercholesterolaemia | 30 | 13.6 | 13.7 | signal |
| 27 | Scratch | 31 | 13.0 | 13.1 | signal |
| 28 | Skin Infection | 33 | 12.8 | 12.9 | signal |
| 29 | Skin Lesion | 80 | 12.7 | 12.9 | signal |
| 30 | Inflammatory Bowel Disease | 28 | 12.3 | 12.4 | signal |
| 31 | Skin Fissures | 52 | 11.9 | 12.1 | signal |
| 32 | Synovitis | 49 | 11.8 | 11.9 | signal |
| 33 | Brain Oedema | 33 | 11.3 | 11.4 | signal |
| 34 | Influenza Like Illness | 215 | 11.3 | 11.8 | signal |
| 35 | Vaginal Discharge | 26 | 11.2 | 11.3 | signal |
| 36 | Influenza | 284 | 11.0 | 11.6 | signal |
| 37 | Therapeutic Product Effect Incomplete | 179 | 11.0 | 11.4 | signal |
| 38 | Gastrointestinal Disorder | 223 | 10.9 | 11.4 | signal |
| 39 | Transaminases Increased | 56 | 10.9 | 11.0 | signal |
| 40 | Localised Infection | 61 | 10.9 | 11.1 | signal |
| 41 | Basal Cell Carcinoma | 39 | 10.8 | 10.9 | signal |
| 42 | Hepatic Cirrhosis | 46 | 10.7 | 10.8 | signal |
| 43 | Hand Deformity | 32 | 10.6 | 10.7 | signal |
| 44 | Body Temperature Decreased | 24 | 10.5 | 10.5 | signal |
| 45 | Treatment Failure | 198 | 10.5 | 10.9 | signal |
| 46 | Drug Ineffective For Unapproved Indication | 132 | 10.3 | 10.5 | signal |
| 47 | Dysphagia | 222 | 10.2 | 10.6 | signal |
| 48 | Tenderness | 24 | 10.0 | 10.0 | signal |
| 49 | Sinusitis | 236 | 9.9 | 10.4 | signal |
| 50 | Hepatic Steatosis | 42 | 9.8 | 9.9 | signal |
| 51 | Skin Disorder | 74 | 9.6 | 9.8 | signal |
| 52 | Secretion Discharge | 27 | 9.5 | 9.5 | signal |
| 53 | Sensory Disturbance | 35 | 9.4 | 9.5 | signal |
| 54 | Decreased Immune Responsiveness | 21 | 9.3 | 9.3 | signal |
| 55 | Chest Discomfort | 219 | 9.3 | 9.7 | signal |
| 56 | Gait Inability | 71 | 9.3 | 9.4 | signal |
| 57 | Face Oedema | 36 | 9.2 | 9.3 | signal |
| 58 | Therapy Partial Responder | 32 | 9.2 | 9.3 | signal |
| 59 | Bacteraemia | 25 | 9.2 | 9.2 | signal |
| 60 | Red Blood Cell Sedimentation Rate Increased | 23 | 9.0 | 9.0 | signal |
| 61 | Sexual Dysfunction | 24 | 8.9 | 8.9 | signal |
| 62 | Muscular Weakness | 233 | 8.9 | 9.3 | signal |
| 63 | Scab | 23 | 8.8 | 8.8 | signal |
| 64 | Rebound Effect | 23 | 8.8 | 8.8 | signal |
| 65 | Rheumatoid Arthritis | 226 | 8.7 | 9.0 | signal |
| 66 | Device Related Infection | 30 | 8.4 | 8.5 | signal |
| 67 | Drug-induced Liver Injury | 59 | 8.3 | 8.4 | signal |
| 68 | Pregnancy | 37 | 7.9 | 8.0 | signal |
| 69 | Clostridium Difficile Infection | 39 | 7.8 | 7.8 | signal |
| 70 | Tuberculosis | 23 | 7.7 | 7.8 | signal |
| 71 | Blood Pressure Increased | 273 | 7.7 | 8.1 | signal |
| 72 | Cellulitis | 88 | 7.6 | 7.7 | signal |
| 73 | Mouth Ulceration | 36 | 7.4 | 7.5 | signal |
| 74 | Nasopharyngitis | 316 | 7.4 | 7.9 | signal |
| 75 | Staphylococcal Infection | 54 | 7.1 | 7.1 | signal |
| 76 | Palpitations | 186 | 6.9 | 7.1 | signal |
| 77 | Sputum Discoloured | 15 | 6.9 | 6.9 | signal |
| 78 | Cerebrovascular Accident | 263 | 6.7 | 7.0 | signal |
| 79 | Poor Quality Sleep | 33 | 6.7 | 6.7 | signal |
| 80 | C-reactive Protein Increased | 56 | 6.7 | 6.7 | signal |
| 81 | Upper Respiratory Tract Infection | 70 | 6.6 | 6.6 | signal |
| 82 | Skin Discolouration | 68 | 6.4 | 6.5 | signal |
| 83 | Drug Exposure During Pregnancy | 51 | 6.4 | 6.5 | signal |
| 84 | Therapy Non-responder | 64 | 6.2 | 6.3 | signal |
| 85 | Hypertensive Crisis | 16 | 6.2 | 6.2 | signal |
| 86 | Pharyngitis Streptococcal | 15 | 6.0 | 6.0 | signal |
| 87 | Abscess | 22 | 6.0 | 6.0 | signal |
| 88 | Wound | 38 | 5.9 | 6.0 | signal |
| 89 | Lymphoma | 21 | 5.9 | 5.9 | signal |
| 90 | Glomerular Filtration Rate Decreased | 16 | 5.7 | 5.7 | signal |
| 91 | Osteopenia | 20 | 5.7 | 5.7 | signal |
| 92 | Confusional State | 209 | 5.6 | 5.8 | signal |
| 93 | Therapeutic Product Effect Decreased | 57 | 5.6 | 5.6 | signal |
| 94 | Colitis | 48 | 5.5 | 5.6 | signal |
| 95 | Product Prescribing Error | 30 | 5.5 | 5.5 | signal |
| 96 | Accident | 15 | 5.5 | 5.5 | signal |
| 97 | Blood Triglycerides Increased | 22 | 5.4 | 5.4 | signal |
| 98 | Hepatitis C | 15 | 5.3 | 5.3 | signal |
| 99 | Drug Intolerance | 117 | 5.3 | 5.4 | signal |
| 100 | Dermatitis | 25 | 5.2 | 5.2 | signal |
| 101 | Pruritus | 441 | 5.1 | 5.5 | signal |
| 102 | Arteriosclerosis | 11 | 5.1 | 5.1 | signal |
| 103 | Seasonal Allergy | 16 | 4.9 | 4.9 | signal |
| 104 | Limb Discomfort | 35 | 4.9 | 4.9 | signal |
| 105 | Obesity | 18 | 4.9 | 4.9 | signal |
| 106 | Burning Sensation | 79 | 4.9 | 4.9 | signal |
| 107 | Musculoskeletal Stiffness | 98 | 4.8 | 4.9 | signal |
| 108 | Dysuria | 41 | 4.8 | 4.8 | signal |
| 109 | Cough | 310 | 4.8 | 5.1 | signal |
| 110 | Pneumonia | 357 | 4.8 | 5.1 | signal |
| 111 | Lower Respiratory Tract Infection | 49 | 4.7 | 4.7 | signal |
| 112 | Ear Pain | 21 | 4.7 | 4.7 | signal |
| 113 | Temperature Intolerance | 11 | 4.7 | 4.7 | signal |
| 114 | Vasculitis | 12 | 4.5 | 4.5 | signal |
| 115 | Renal Disorder | 48 | 4.4 | 4.5 | signal |
| 116 | Liver Function Test Abnormal | 30 | 4.4 | 4.5 | signal |
| 117 | Arthropathy | 57 | 4.4 | 4.5 | signal |
| 118 | Heart Rate Decreased | 36 | 4.4 | 4.4 | signal |
| 119 | Infection | 146 | 4.4 | 4.5 | signal |
| 120 | Osteoarthritis | 43 | 4.4 | 4.4 | signal |
| 121 | Skin Ulcer | 26 | 4.4 | 4.4 | signal |
| 122 | Pyrexia | 347 | 4.3 | 4.6 | signal |
| 123 | Toxic Epidermal Necrolysis | 15 | 4.3 | 4.3 | signal |
| 124 | Hepatotoxicity | 22 | 4.3 | 4.3 | signal |
| 125 | Blood Potassium Increased | 16 | 4.3 | 4.3 | signal |
| 126 | Pulmonary Congestion | 13 | 4.2 | 4.3 | signal |
| 127 | Inappropriate Schedule Of Product Administration | 172 | 4.2 | 4.3 | signal |
| 128 | Diarrhoea Haemorrhagic | 9 | 4.2 | 4.2 | signal |
| 129 | Stress | 69 | 4.2 | 4.2 | signal |
| 130 | Dry Skin | 126 | 4.1 | 4.2 | signal |
| 131 | Diabetes Mellitus | 73 | 4.1 | 4.2 | signal |
| 132 | Haematocrit Decreased | 19 | 4.1 | 4.1 | signal |
| 133 | Pulmonary Mass | 14 | 4.1 | 4.1 | signal |
| 134 | Blood Iron Decreased | 11 | 4.0 | 4.0 | signal |
| 135 | Fungal Infection | 31 | 4.0 | 4.0 | signal |
| 136 | Contraindicated Product Administered | 28 | 4.0 | 4.0 | signal |
| 137 | Erythema | 190 | 4.0 | 4.1 | signal |
| 138 | Back Injury | 10 | 4.0 | 4.0 | signal |
| 139 | Type 2 Diabetes Mellitus | 31 | 4.0 | 4.0 | signal |
| 140 | Ligament Sprain | 9 | 3.9 | 4.0 | signal |
| 141 | Blister | 51 | 3.9 | 4.0 | signal |
| 142 | Hypersomnia | 26 | 3.9 | 3.9 | signal |
| 143 | Anxiety | 259 | 3.9 | 4.1 | signal |
| 144 | Liver Disorder | 40 | 3.9 | 3.9 | signal |
| 145 | Drug Resistance | 23 | 3.9 | 3.9 | signal |
| 146 | Malignant Melanoma | 12 | 3.9 | 3.9 | signal |
| 147 | Quality Of Life Decreased | 12 | 3.9 | 3.9 | signal |
| 148 | Eye Infection | 10 | 3.9 | 3.9 | signal |
| 149 | Drug Ineffective | 1,170 | 3.8 | 4.8 | signal |
| 150 | Nasal Congestion | 52 | 3.8 | 3.9 | signal |
| 151 | Skin Cancer | 19 | 3.8 | 3.8 | signal |
| 152 | Tooth Abscess | 9 | 3.8 | 3.8 | signal |
| 153 | Therapeutic Response Decreased | 53 | 3.8 | 3.8 | signal |
| 154 | Wrong Technique In Device Usage Process | 40 | 3.8 | 3.8 | signal |
| 155 | Neoplasm | 10 | 3.8 | 3.8 | signal |
| 156 | Blood Pressure Systolic Increased | 17 | 3.8 | 3.8 | signal |
| 157 | Peripheral Swelling | 133 | 3.8 | 3.8 | signal |
| 158 | Impaired Healing | 28 | 3.7 | 3.7 | signal |
| 159 | Caesarean Section | 10 | 3.7 | 3.7 | signal |
| 160 | Incontinence | 9 | 3.7 | 3.7 | signal |
| 161 | Abortion Induced | 8 | 3.7 | 3.7 | signal |
| 162 | Hyperlipidaemia | 10 | 3.6 | 3.6 | signal |
| 163 | Tooth Infection | 11 | 3.6 | 3.6 | signal |
| 164 | Hypertension | 174 | 3.6 | 3.6 | signal |
| 165 | Bronchitis | 61 | 3.5 | 3.6 | signal |
| 166 | Respiratory Tract Infection | 21 | 3.5 | 3.5 | signal |
| 167 | Fall | 268 | 3.5 | 3.6 | signal |
| 168 | Fistula | 9 | 3.5 | 3.5 | signal |
| 169 | Pain | 490 | 3.4 | 3.7 | signal |
| 170 | Back Disorder | 13 | 3.4 | 3.5 | signal |
| 171 | Diverticulitis | 22 | 3.4 | 3.5 | signal |
| 172 | Dry Throat | 8 | 3.4 | 3.4 | signal |
| 173 | Malaise | 345 | 3.4 | 3.6 | signal |
| 174 | Myocardial Ischaemia | 9 | 3.4 | 3.4 | signal |
| 175 | Electrolyte Imbalance | 9 | 3.4 | 3.4 | signal |
| 176 | Leukocytosis | 14 | 3.3 | 3.4 | signal |
| 177 | Restless Legs Syndrome | 14 | 3.3 | 3.3 | signal |
| 178 | Madarosis | 9 | 3.3 | 3.3 | signal |
| 179 | Rash Erythematous | 36 | 3.3 | 3.3 | signal |
| 180 | Blood Alkaline Phosphatase Increased | 19 | 3.3 | 3.3 | signal |
| 181 | Retinal Detachment | 7 | 3.3 | 3.3 | signal |
| 182 | Joint Swelling | 91 | 3.3 | 3.3 | signal |
| 183 | Gastroenteritis | 11 | 3.3 | 3.3 | signal |
| 184 | Hepatic Enzyme Increased | 51 | 3.2 | 3.3 | signal |
| 185 | Bursitis | 9 | 3.2 | 3.2 | signal |
| 186 | Hypoglycaemia | 36 | 3.2 | 3.2 | signal |
| 187 | Drug Eruption | 13 | 3.2 | 3.2 | signal |
| 188 | Laryngitis | 8 | 3.2 | 3.2 | signal |
| 189 | Wound Infection | 8 | 3.2 | 3.2 | signal |
| 190 | No Therapeutic Response | 9 | 3.1 | 3.2 | signal |
| 191 | Thrombotic Microangiopathy | 7 | 3.1 | 3.1 | signal |
| 192 | Oral Herpes | 14 | 3.1 | 3.1 | signal |
| 193 | Osteomyelitis | 13 | 3.1 | 3.1 | signal |
| 194 | Ear Infection | 19 | 3.1 | 3.1 | signal |
| 195 | Mass | 10 | 3.1 | 3.1 | signal |
| 196 | Wheezing | 42 | 3.1 | 3.1 | signal |
| 197 | Condition Aggravated | 214 | 3.1 | 3.2 | signal |
| 198 | Irritable Bowel Syndrome | 15 | 3.0 | 3.0 | signal |
| 199 | Inflammation | 36 | 3.0 | 3.0 | signal |
| 200 | Cerebral Infarction | 17 | 3.0 | 3.0 | signal |
| 201 | Therapeutic Response Shortened | 22 | 3.0 | 3.0 | signal |
| 202 | Eyelid Ptosis | 7 | 3.0 | 3.0 | signal |
| 203 | Rash Pruritic | 37 | 3.0 | 3.0 | signal |
| 204 | Pruritus Generalised | 15 | 3.0 | 3.0 | signal |
| 205 | Sepsis | 76 | 2.9 | 3.0 | signal |
| 206 | Blood Pressure Decreased | 45 | 2.9 | 3.0 | signal |
| 207 | Drug Effect Incomplete | 25 | 2.9 | 2.9 | signal |
| 208 | Local Swelling | 12 | 2.9 | 2.9 | signal |
| 209 | Pain In Extremity | 200 | 2.9 | 3.0 | signal |
| 210 | Acute Myocardial Infarction | 20 | 2.9 | 2.9 | signal |
| 211 | Menstruation Delayed | 7 | 2.9 | 2.9 | signal |
| 212 | Asthenia | 248 | 2.9 | 3.0 | signal |
| 213 | Arthralgia | 272 | 2.8 | 2.9 | signal |
| 214 | Hypercalcaemia | 8 | 2.8 | 2.8 | signal |
| 215 | Ovarian Cancer | 6 | 2.8 | 2.8 | signal |
| 216 | Intervertebral Disc Degeneration | 6 | 2.8 | 2.8 | signal |
| 217 | Pharyngitis | 8 | 2.8 | 2.8 | signal |
| 218 | Scar | 11 | 2.8 | 2.8 | signal |
| 219 | Urticaria | 106 | 2.8 | 2.8 | signal |
| 220 | Leukaemia | 6 | 2.8 | 2.8 | signal |
| 221 | Glycosylated Haemoglobin Increased | 16 | 2.7 | 2.8 | signal |
| 222 | Contusion | 61 | 2.7 | 2.8 | signal |
| 223 | Osteonecrosis | 21 | 2.7 | 2.7 | signal |
| 224 | Rectal Haemorrhage | 27 | 2.7 | 2.7 | signal |
| 225 | Hepatitis | 16 | 2.7 | 2.7 | signal |
| 226 | Systemic Lupus Erythematosus | 22 | 2.7 | 2.7 | signal |
| 227 | Fatigue | 483 | 2.7 | 2.9 | signal |
| 228 | Injection Site Bruising | 49 | 2.7 | 2.7 | signal |
| 229 | Vomiting | 289 | 2.7 | 2.8 | signal |
| 230 | Oropharyngeal Pain | 57 | 2.7 | 2.7 | signal |
| 231 | Dyspepsia | 60 | 2.6 | 2.7 | signal |
| 232 | Internal Haemorrhage | 7 | 2.6 | 2.6 | signal |
| 233 | Toothache | 11 | 2.6 | 2.6 | signal |
| 234 | Neoplasm Malignant | 40 | 2.6 | 2.6 | signal |
| 235 | Joint Range Of Motion Decreased | 8 | 2.6 | 2.6 | signal |
| 236 | Eyelid Oedema | 7 | 2.6 | 2.6 | signal |
| 237 | Headache | 372 | 2.6 | 2.7 | signal |
| 238 | Hypothermia | 6 | 2.6 | 2.6 | signal |
| 239 | Polyneuropathy | 7 | 2.5 | 2.5 | signal |
| 240 | Gamma-glutamyltransferase Increased | 13 | 2.5 | 2.5 | signal |
| 241 | Blood Creatinine Increased | 38 | 2.5 | 2.5 | signal |
| 242 | Folliculitis | 6 | 2.5 | 2.5 | signal |
| 243 | Dry Eye | 28 | 2.5 | 2.5 | signal |
| 244 | Gastric Ulcer | 11 | 2.5 | 2.5 | signal |
| 245 | Ventricular Extrasystoles | 6 | 2.5 | 2.5 | no signal |
| 246 | Skin Burning Sensation | 41 | 2.5 | 2.5 | signal |
| 247 | Herpes Zoster | 33 | 2.5 | 2.5 | signal |
| 248 | Product Use Issue | 107 | 2.5 | 2.5 | signal |
| 249 | Skin Reaction | 8 | 2.5 | 2.5 | signal |
| 250 | Ulcer | 9 | 2.4 | 2.4 | signal |
| 251 | Lymphadenopathy | 20 | 2.4 | 2.4 | signal |
| 252 | Cyst | 7 | 2.4 | 2.4 | signal |
| 253 | Joint Injury | 12 | 2.4 | 2.4 | signal |
| 254 | Discomfort | 34 | 2.4 | 2.4 | signal |
| 255 | Nausea | 441 | 2.4 | 2.6 | signal |
| 256 | Mobility Decreased | 40 | 2.4 | 2.4 | signal |
| 257 | Product Use In Unapproved Indication | 136 | 2.4 | 2.4 | signal |
| 258 | Hair Colour Changes | 7 | 2.4 | 2.4 | signal |
| 259 | Injection Site Haemorrhage | 44 | 2.4 | 2.4 | signal |
| 260 | Product Administration Error | 11 | 2.4 | 2.4 | signal |
| 261 | Off Label Use | 476 | 2.4 | 2.5 | signal |
| 262 | Tooth Fracture | 6 | 2.4 | 2.4 | no signal |
| 263 | Rash Maculo-papular | 12 | 2.3 | 2.3 | signal |
| 264 | Cardiomyopathy | 8 | 2.3 | 2.3 | signal |
| 265 | Abdominal Discomfort | 90 | 2.3 | 2.4 | signal |
| 266 | Pancreatitis Acute | 12 | 2.3 | 2.3 | signal |
| 267 | Rash Papular | 12 | 2.3 | 2.3 | signal |
| 268 | Lung Neoplasm Malignant | 22 | 2.3 | 2.3 | signal |
| 269 | Depressed Mood | 28 | 2.3 | 2.3 | signal |
| 270 | Gastric Disorder | 18 | 2.2 | 2.2 | signal |
| 271 | Sinus Bradycardia | 5 | 2.2 | 2.2 | no signal |
| 272 | Alopecia | 101 | 2.2 | 2.2 | signal |
| 273 | Splenomegaly | 6 | 2.2 | 2.2 | no signal |
| 274 | Spinal Pain | 6 | 2.2 | 2.2 | no signal |
| 275 | Back Pain | 119 | 2.2 | 2.2 | signal |
| 276 | Lip Swelling | 17 | 2.2 | 2.2 | signal |
| 277 | Inability To Afford Medication | 5 | 2.2 | 2.2 | no signal |
| 278 | Bladder Disorder | 5 | 2.2 | 2.2 | no signal |
| 279 | Upper Limb Fracture | 10 | 2.2 | 2.2 | signal |
| 280 | Blood Test Abnormal | 7 | 2.2 | 2.2 | no signal |
| 281 | Eczema | 25 | 2.1 | 2.2 | signal |
| 282 | Liver Injury | 12 | 2.1 | 2.1 | signal |
| 283 | Poor Quality Product Administered | 5 | 2.1 | 2.1 | no signal |
| 284 | Subdural Haematoma | 7 | 2.1 | 2.1 | no signal |
| 285 | Dysstasia | 14 | 2.1 | 2.1 | signal |
| 286 | Palmar-plantar Erythrodysaesthesia Syndrome | 11 | 2.0 | 2.0 | signal |
| 287 | Infusion Site Pain | 6 | 2.0 | 2.0 | no signal |
| 288 | Throat Irritation | 21 | 2.0 | 2.0 | signal |
| 289 | Colon Cancer | 7 | 2.0 | 2.0 | no signal |
| 290 | Haematuria | 16 | 2.0 | 2.0 | signal |
| 291 | Disease Recurrence | 22 | 2.0 | 2.0 | no signal |
| 292 | Mucosal Inflammation | 12 | 2.0 | 2.0 | no signal |
| 293 | Kidney Infection | 9 | 2.0 | 2.0 | no signal |
| 294 | Myalgia | 76 | 1.9 | 1.9 | no signal |
| 295 | Emotional Distress | 54 | 1.9 | 1.9 | no signal |
| 296 | Limb Injury | 12 | 1.9 | 1.9 | no signal |
| 297 | Chronic Obstructive Pulmonary Disease | 23 | 1.9 | 1.9 | no signal |
| 298 | Illness | 44 | 1.9 | 1.9 | no signal |
| 299 | Conjunctivitis | 8 | 1.9 | 1.9 | no signal |
| 300 | Metastases To Lung | 5 | 1.9 | 1.9 | no signal |
| 301 | Dysphonia | 25 | 1.9 | 1.9 | no signal |
| 302 | Lymphopenia | 6 | 1.8 | 1.8 | no signal |
| 303 | Coronary Artery Disease | 13 | 1.8 | 1.8 | no signal |
| 304 | Pericarditis | 7 | 1.8 | 1.8 | no signal |
| 305 | Joint Stiffness | 11 | 1.8 | 1.8 | no signal |
| 306 | Nervousness | 22 | 1.8 | 1.8 | no signal |
| 307 | Wrist Fracture | 5 | 1.8 | 1.8 | no signal |
| 308 | Myelodysplastic Syndrome | 6 | 1.8 | 1.8 | no signal |
| 309 | Fibromyalgia | 10 | 1.8 | 1.8 | no signal |
| 310 | Circulatory Collapse | 7 | 1.8 | 1.8 | no signal |
| 311 | Frequent Bowel Movements | 11 | 1.8 | 1.8 | no signal |
| 312 | Jaundice | 11 | 1.8 | 1.8 | no signal |
| 313 | Metrorrhagia | 7 | 1.8 | 1.8 | no signal |
| 314 | Libido Decreased | 5 | 1.7 | 1.7 | no signal |
| 315 | Angioedema | 17 | 1.7 | 1.7 | no signal |
| 316 | Transient Ischaemic Attack | 13 | 1.7 | 1.7 | no signal |
| 317 | Nodule | 5 | 1.7 | 1.7 | no signal |
| 318 | Lung Infection | 6 | 1.6 | 1.6 | no signal |
| 319 | Acne | 29 | 1.6 | 1.7 | no signal |
| 320 | Immune System Disorder | 5 | 1.6 | 1.6 | no signal |
| 321 | Hot Flush | 28 | 1.6 | 1.6 | no signal |
| 322 | Uveitis | 5 | 1.6 | 1.6 | no signal |
| 323 | Metastases To Bone | 6 | 1.6 | 1.6 | no signal |
| 324 | Pulmonary Thrombosis | 4 | 1.6 | 1.6 | no signal |
| 325 | Asthma | 41 | 1.6 | 1.6 | no signal |
| 326 | Choking | 7 | 1.6 | 1.6 | no signal |
| 327 | Foot Deformity | 4 | 1.6 | 1.6 | no signal |
| 328 | Nephropathy Toxic | 4 | 1.6 | 1.6 | no signal |
| 329 | Intentional Product Misuse | 31 | 1.5 | 1.5 | no signal |
| 330 | Cardiovascular Disorder | 9 | 1.5 | 1.5 | no signal |
| 331 | Anaphylactic Shock | 9 | 1.5 | 1.5 | no signal |
| 332 | Impaired Quality Of Life | 5 | 1.5 | 1.5 | no signal |
| 333 | Breast Cancer | 32 | 1.5 | 1.5 | no signal |
| 334 | Ischaemic Stroke | 6 | 1.5 | 1.5 | no signal |
| 335 | Product Administered At Inappropriate Site | 6 | 1.4 | 1.4 | no signal |
| 336 | Thyroid Cancer | 4 | 1.4 | 1.4 | no signal |
| 337 | Skin Irritation | 15 | 1.4 | 1.4 | no signal |
| 338 | Blood Count Abnormal | 5 | 1.4 | 1.4 | no signal |
| 339 | Pemphigus | 4 | 1.4 | 1.4 | no signal |
| 340 | Drug Administration Error | 10 | 1.4 | 1.4 | no signal |
| 341 | Incorrect Dose Administered By Device | 8 | 1.4 | 1.4 | no signal |
| 342 | Drug Reaction With Eosinophilia And Systemic Symptoms | 8 | 1.4 | 1.4 | no signal |
| 343 | Myocardial Infarction | 55 | 1.4 | 1.4 | no signal |
| 344 | Cardiac Disorder | 29 | 1.3 | 1.3 | no signal |
| 345 | Ankylosing Spondylitis | 4 | 1.3 | 1.3 | no signal |
| 346 | Rash Generalised | 8 | 1.3 | 1.3 | no signal |
| 347 | Incorrect Dose Administered | 67 | 1.3 | 1.3 | no signal |
| 348 | Toxic Skin Eruption | 3 | 1.3 | 1.3 | no signal |
| 349 | Product Prescribing Issue | 6 | 1.3 | 1.3 | no signal |
| 350 | Device Occlusion | 4 | 1.2 | 1.2 | no signal |
| 351 | Eosinophilia | 5 | 1.2 | 1.2 | no signal |
| 352 | Drug Effect Less Than Expected | 4 | 1.2 | 1.2 | no signal |
| 353 | Maternal Exposure During Pregnancy | 25 | 1.2 | 1.2 | no signal |
| 354 | Drug Effective For Unapproved Indication | 8 | 1.2 | 1.2 | no signal |
| 355 | Injection Site Pain | 79 | 1.1 | 1.1 | no signal |
| 356 | Drug Prescribing Error | 5 | 1.1 | 1.1 | no signal |
| 357 | Inappropriate Schedule Of Drug Administration | 18 | 1.1 | 1.1 | no signal |
| 358 | Hepatic Cancer | 6 | 1.1 | 1.1 | no signal |
| 359 | Prostate Cancer | 20 | 1.1 | 1.1 | no signal |
| 360 | Hepatic Cytolysis | 3 | 1.1 | 1.1 | no signal |
| 361 | Product Dose Omission | 16 | 1.0 | 1.0 | no signal |
| 362 | Dermatitis Atopic | 12 | 1.0 | 1.0 | no signal |
| 363 | Suicidal Ideation | 22 | 1.0 | 1.0 | no signal |
| 364 | Injection Site Irritation | 3 | 1.0 | 1.0 | no signal |
| 365 | Product Dispensing Error | 5 | 1.0 | 1.0 | no signal |
| 366 | Anorexia | 3 | 1.0 | 1.0 | no signal |
| 367 | Renal Cancer | 11 | 1.0 | 1.0 | no signal |
| 368 | Colitis Ulcerative | 10 | 1.0 | 1.0 | no signal |
| 369 | Injection Site Reaction | 15 | 0.9 | 0.9 | no signal |
| 370 | Bladder Cancer | 12 | 0.9 | 0.9 | no signal |
| 371 | Premature Baby | 6 | 0.9 | 0.9 | no signal |
| 372 | Device Failure | 3 | 0.9 | 0.9 | no signal |
| 373 | Product Storage Error | 17 | 0.8 | 0.8 | no signal |
| 374 | Device Malfunction | 13 | 0.8 | 0.8 | no signal |
| 375 | Menorrhagia | 3 | 0.7 | 0.7 | no signal |
| 376 | Breast Cancer Female | 4 | 0.6 | 0.6 | no signal |
| 377 | Myelosuppression | 5 | 0.6 | 0.6 | no signal |
| 378 | Injection Site Warmth | 3 | 0.6 | 0.6 | no signal |
| 379 | Pancreatic Carcinoma | 4 | 0.6 | 0.6 | no signal |
| 380 | Device Issue | 12 | 0.6 | 0.6 | no signal |
| 381 | Injection Site Swelling | 10 | 0.6 | 0.6 | no signal |
| 382 | Gastric Cancer | 3 | 0.5 | 0.5 | no signal |
| 383 | Injection Site Erythema | 14 | 0.5 | 0.5 | no signal |
| 384 | Oesophageal Carcinoma | 3 | 0.4 | 0.4 | no signal |
| 385 | Colorectal Cancer | 4 | 0.4 | 0.4 | no signal |
| 386 | Drug Dependence | 13 | 0.3 | 0.3 | no signal |
| 387 | Device Difficult To Use | 4 | 0.3 | 0.3 | no signal |